Secondary prevention: improving outcomes following myocardial infarction.
Maggioni
A P
AP
ANMCO Research Centre, Via La Marmora 34, 50121 Firenze, Italy. maggioni@anmco.it
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D015996:Survival Rate; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy
D000806:Angiotensin-Converting Enzyme Inhibitors